Vacancy for Clinical Research Analyst at Duke Nurses | Durham
Duke Nurses are transforming the future of patient care. Guided by our mission, vision and values, we are committed to excellence. We are leaders, innovators, and educators. We are passionate about what we do. Duke University Health System Nursing is committed to quality care of our patients, their family members, and the community through excellence in leadership, practice, innovation, and education.
Coordinate DOCR’s portion of the Clinical Research Institutional Approval process. Review study documents to complete required start-up build in OnCore and meet with study teams to review the billing grid prior to the study orders and Beacon builds for Maestro Care. Collaborate with teams internal and external to DOCR to assess study readiness prior to go-live. Provide clinical guidance and training to Clinical Research Analysts regarding protocol interpretation and billing grid creation.
Post : CLINICAL RESEARCH ANALYST
[adsense:336x280:8701650588]
GeBBS is a leading Healthcare outsourcing solutions company based in Englewood Cliffs, 
Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world. Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.
Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs nearly 6000 people in over 80 countries. It has twelve manufacturing facilities in four countries and has five R&D centres.
Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.
